Months after Massachusetts voters rejected a ballot question that would permit adults to use and grow certain psychedelic ...

The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting ...

Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD) hasn't made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate ...

Craske and her colleagues hypothesized that targeting this mechanism for reward sensitivity could help strengthen affected ...

There are multiple chapters near you. Select your preferred chapter.

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

For patients with metastatic castration-resistant prostate cancer (mCRPC) unselected for homologous recombination repair (HRR ...

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and ...

Spinal muscular atrophy (SMA) is a progressive neurodegenerative disorder set in motion before birth. Scientists at St. Jude Children's Research Hospital led the first in uterotreatment of SMA with ...

Broken Heart Syndrome mimics symptoms of a heart attack. It can strike after a stressful event, such as the loss of a loved ...

People with sleep apnea experience blood pressure dips at less than 10%, which increases their risk for cardiovascular disease. Sleep apnea treatment can help lower blood pressure because it improves ...